Brokerages Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $334.45

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and nine have given a buy recommendation […]

Leave a Reply

Your email address will not be published.

Previous post Alpha Services and Holdings S.A. (OTCMKTS:ALBKF) Short Interest Up 26.0% in August
Next post Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Recommendation of “Moderate Buy” by Brokerages